Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Subakir, S. B.
Right arrow Articles by Affandi, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Subakir, S. B.
Right arrow Articles by Affandi, B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 11, No. suppl_2, pp. 51-55, 1996
© 1996 European Society of Human Reproduction and Embryology

Endometrial angiogenic response in Norplant users

S. B. Subakir1,4, W. Hadisaputra2, A. E. Handoyo3 and B. Affandi2

1 Departments of Physiology, Faculty of Medicine, University of Indonesia Jakarta 10430, Indonesia 2 Obstetrics and Gynaecology, Faculty of Medicine, University of Indonesia Jakarta 10430, Indonesia 3 Phannacology, Faculty of Medicine, University of Indonesia Jakarta 10430, Indonesia

Correspondence: 4To whom correspondence should be addressed

The levonorgestrel-releasing subdermal contraceptive implant Norplant® is well accepted among Indonesian users, despite the problems with irregular and prolonged menstrual bleeding. Bleeding can be the major reason for women discontinuing their use of Norplant The causes of endometrial bleeding may include disturbances in endometrial regeneration and angio-genesis. The aim of this study was to investigate endometrial angiogenic activity in Norplant users and to compare it to that in the normal menstrua] cycle. The study also aimed to determine the correlation between endometrial angiogenic activity and plasma concentrations of oestradiol, progesterone, sex hormone binding globulin and levonorgestrel, as well as the free levonorgestrel index. The subjects for this study were selected from Norplant users with an exposure of between 3 and 12 months. Endometrial angiogenic response was assayed using an endothelial cell migration assay. Six blood samples to monitor oestradiol and progesterone concentrations were taken during the 2 weeks prior to endometrial biopsy. Samples for the analysis of sex hormone binding globulin and levonorgestrel were taken on the day of biopsy. The results showed that the median score of endometrial angiogenic activity in the 30 women used as controls were significantly higher than the 40 Norplant acceptors (z = –3.80, one tail, P < 0.001). There was no significant correlation between the endothelial migration score and peripheral hormonal concentrations or the free levonorgestrel index in Norplant users. There was no difference in the endometrial angiogenic activity in endometrium with and without bleeding problems. However, it is interesting to note that four Norplant acceptors who had an endothelial cell migration score ≥1.0 had the lowest free levonorgestrel index.

Key words: angiogenesis/endometrial bleeding/endothelial cell/free levonorgestrel index/Norplant


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.